designed a CAR-NK targeting the CD73 adenosine axis, which inhibited adenosinergic metabolism in an NSCLC model, induced tumor stasis, and promoted NK cell infiltration into CD73-expressing tumors (134). The gene discussed is NT5E; the disease is non-small cell lung carcinoma.